The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7403
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly ; volume:19 ; number:2 ; day:20 ; month:8 ; year:2015 ; pages:210-221 ; date:4.2016
Pituitary ; 19, Heft 2 (20.8.2015), 210-221, 4.2016
- Urheber
-
Colao, Annamaria
- Beteiligte Personen und Organisationen
- DOI
-
10.1007/s11102-015-0677-y
- URN
-
urn:nbn:de:1111-2016032428992
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Colao, Annamaria
- Auriemma, Renata S.
- Pivonello, Rosario
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
A Pituitary Society update to acromegaly management guidelines
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Metastatic pituitary carcinoma in a patient with acromegaly: a case report
Outcomes in Pituitary Adenoma Causing Acromegaly Following Endoscopic Endonasal Transsphenoidal Surgery
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
Long-term control of acromegaly after pituitary surgery in South-Eastern Norway
Acromegaly
Octreotate: a new somatostatin analogue for tumor imaging and radionuclide therapy
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment